Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Daphne E. Smith Marsh

Daphne E. Smith Marsh

Clinical Assistant Professor, College of Pharmacy - Pharmacy Practice
Director of Diversity, Equity, Engagement and Inclusion, Department of Pharmacy Practice



833 South Wood Street, Chicago, IL

Office Phone:

(312) 413-7871 (work)

Related Sites:

About Heading link

Clinical pharmacist, diabetes educator and faculty member with more than 25 years of experience, which encompasses compassionate, culturally respectful, patient-centered care.

Research Interests:
Diabetes management in indigent population, medication therapy management.

Teaching Statement:
Didactic and experiential instruction provided for professional pharmacy, medical, nursing and nutrition students and residents, with focus on diabetes therapeutic management and lifestyle modification.

Teaching and Supervision Heading link

Honors College Seminar (HON 201), 4/9/2024 – 4/9/2024
Chronic Kidney Disease (PMPR 381), 3/11/2024 – 3/11/2024
Pathophysiology, Drug Action and Therapeutics (PHAR 502), 2/16/2024 – 2/29/2024
Introductory Pharmacy Practice (PHAR 414), 1/23/2024 – 1/30/2024
Introduction to Pharmacy Practice (PHAR 411), 9/20/2023 – 9/21/2023
Clinical Aspects of Diabetes (PMPR 362), 8/21/2023 – 12/1/2023
PHAR 601: Ambulatory Care (PHAR 601), 8/14/2023 – 12/14/2023
Advanced Topics in Diabetes Management (HN 505), 7/19/2023 – 7/19/2023
PMPR 381: Chronic Kidney Disease (PMPR 381), 3/13/2023 – 3/13/2023

Selected Grants

Building Health Communities in Suburban Cook County/PRogram to Educate & VaccinatE uNderserved members of The public (PREVENT) Pilot, Mobile Care Fdn., 11/1/2022 - 5/31/2024, Obligated Amount: $17325; Anticipated Amount: $17325

Selected Publications

Gerber, Ben S, Biggers, Alana, Tilton, Jessica J, Marsh, Daphne E Smith, Lane, Rachel, Mihailescu, Dan, Lee, JungAe, Sharp, Lisa K. (2023). Mobile Health Intervention in Patients With Type 2 Diabetes. JAMA Network Open, 6, (9), e2333629. doi:10.1001/jamanetworkopen.2023.33629.

Adimadhyam, Sruthi, Lee, Todd A, Calip, Gregory S, Marsh, Daphne E Smith, Layden, Brian T, Schumock, Glen T. (2019). Sodium‐glucose co‐transporter 2 inhibitors and the risk of fractures: A propensity score‐matched cohort study. Pharmacoepidemiology and Drug Safety, 28, (12), 1629-1639. doi:10.1002/pds.4900.

Adimadhyam, Sruthi, Schumock, Glen T, Calip, Gregory S, Marsh, Daphne E Smith, Layden, Brian T, Lee, Todd A. (2019). Increased risk of mycotic infections associated with sodium–glucose co‐transporter 2 inhibitors: a prescription sequence symmetry analysis. British Journal of Clinical Pharmacology, 85, (1), 160-168. doi:10.1111/bcp.13782.

Adimadhyam, Sruthi, Lee, Todd A, Calip, Gregory S, Marsh, Daphne E Smith, Layden, Brian T, Schumock, Glen T. (2018). Risk of amputations associated with SGLT2 inhibitors compared to DPP‐4 inhibitors: A propensity‐matched cohort study. Diabetes Obesity and Metabolism, 20, (12), 2792-2799. doi:10.1111/dom.13459.

Smith Marsh, DE. (2015). Managing adverse events related to SGLT2 inhibitors: What a pharmacist needs to know to optimize clinical outcomes. Pharmacy Times, 81, (4).

Smith-Marsh, D. (2013). Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance.. Drugs of Today, 49, (8), 499-507. doi:10.1358/dot.2013.49.8.2002839.

Gerber, Ben S, Cano, Alejandra I, Caceres, Maria L, Smith, Daphne E, Wilken, Lori A, Michaud, Jessica B, Ruggiero, Laurie A, Sharp, Lisa K. (2010). A Pharmacist and Health Promoter Team to Improve Medication Adherence Among Latinos with Diabetes. Annals of Pharmacotherapy, 44, (1), 70-79. doi:10.1345/aph.1m389.

Scheiner, Gary, Sobel, Robert J, Smith, Daphne E, Pick, Anthony J, Kruger, Davida, King, Jacqueline, Green, Karen. (2009). Insulin Pump Therapy Guidelines for Successful Outcomes. The Science of Diabetes Self-Management and Care, 35, (2_suppl), 29s-41s. doi:10.1177/0145721709333493.

Smith Marsh, Daphne, Elmes, Abigail, McQuade, Brianna, Jarrett, Jennie. To reduce or not to reduce? Insulin dose adjustments upon starting GLP-1 receptor agonists. KeePosted.

Professional Leadership

ICHP DEI Committee, ICHP, 7/20/2023 - Present

ADA Wellness Village Committee, 1/6/2020 - Present

ADA Step Out Planning Committee, 7/1/2019 - 9/30/2019

Notable Honors

2023, UIC SNPhA Service Recognition, University of Illinois at Chicago


Doctor of Pharmacy, University of Illinois at Chicago, United States, 1997
Pre-Pharmacy Education, Jackson State University, United States, 1989
Pre-Pharmacy Education, Creighton University, United States, 1990

Postgraduate Training:
Pharmacy Practice Residency, Saint Elizabeth Hospital, United States, 1998

Licensures and Certifications

Registered Pharmacist #051-286220, State of Illinois, Date Not Set - Present
Certified Diabetes Care and Education Specialist, Association of Diabetes Care and Education Specialists, 12/1/2001 - Present
Board Certified-Advanced Diabetes Management, Association of Diabetes Care and Education Specialists, 6/20/2016 - 6/20/2026
Diversity, Equity, and Inclusion Certificate, American Society of Health-System Pharmacists, 4/30/2023 - Present